CME Group Inc. (CME) Financial Ratios
26 years of historical data (2000–2025) · Financial Services · Financial - Data & Stock Exchanges
EV/EBITDA
↓
22.95
+7% vs avg
5yr avg: 21.37
30Y Low4.3·High37.4
P/FCF
↓
24.81
-1% vs avg
5yr avg: 25.10
30Y Low12.3·High46.6
P/B Ratio
↑
3.60
↑+23% vs avg
5yr avg: 2.93
30Y Low0.7·High11.8
ROE
↑
14.6%
↓+23% vs avg
5yr avg: 11.9%
30Y Low-4%·High33%
Debt/EBITDA
↓
0.83
↓-11% vs avg
5yr avg: 0.94
30Y Low0.0·High22.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CME Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
CME Group Inc. trades at 25.7x earnings, roughly in line with its 5-year average of 25.3x, sitting at the 54th percentile of its historical range. Compared to the Financial Services sector median P/E of 13.3x, the stock trades at a premium of 93%. On a free-cash-flow basis, the stock trades at 24.8x P/FCF, roughly in line with the 5-year average of 25.1x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $104.1B | $98.4B | $83.6B | $75.7B | $60.4B | $82.0B | $65.3B | $71.9B | $64.7B | $49.7B | $39.1B |
| Enterprise Value | $103.4B | $97.7B | $84.1B | $76.2B | $61.1B | $82.6B | $67.1B | $74.1B | $67.7B | $94.2B | $77.0B |
| P/E Ratio → | 25.70 | 24.47 | 24.02 | 23.77 | 22.72 | 31.34 | 31.01 | 33.96 | 32.95 | 12.23 | 25.46 |
| P/S Ratio | 15.96 | 15.09 | 13.64 | 13.57 | 12.03 | 17.49 | 13.36 | 14.77 | 15.01 | 13.63 | 10.88 |
| P/B Ratio | 3.60 | 3.42 | 3.16 | 2.83 | 2.25 | 2.99 | 2.48 | 2.75 | 2.49 | 2.22 | 1.92 |
| P/FCF | 24.81 | 23.46 | 23.24 | 22.42 | 20.36 | 36.04 | 25.92 | 29.62 | 27.82 | 28.26 | 24.07 |
| P/OCF | 24.33 | 23.00 | 22.65 | 21.92 | 19.76 | 34.13 | 24.03 | 26.90 | 26.49 | 27.00 | 22.79 |
P/E links to full P/E history page with 30-year chart
CME EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
CME Group Inc.'s enterprise value stands at 23.0x EBITDA, 7% above its 5-year average of 21.4x. The Financial Services sector median is 11.4x, placing the stock at a 101% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 14.98 | 13.72 | 13.66 | 12.18 | 17.62 | 13.74 | 15.22 | 15.71 | 25.85 | 21.42 |
| EV / EBITDA | 22.95 | 21.69 | 19.71 | 20.12 | 18.09 | 27.26 | 21.63 | 15.22 | 15.48 | 25.85 | 20.86 |
| EV / EBIT | 24.45 | 17.94 | 17.89 | 17.67 | 16.73 | 23.33 | 23.22 | 25.84 | 23.06 | 35.64 | 31.94 |
| EV / FCF | — | 23.30 | 23.39 | 22.57 | 20.60 | 36.31 | 26.64 | 30.53 | 29.13 | 53.57 | 47.41 |
CME Profitability
Margins and return-on-capital ratios measuring operating efficiency
CME Group Inc. earns an operating margin of 64.9%, significantly above the Financial Services sector average of 21.4%. Operating margins have expanded from 61.6% to 64.9% over the past 3 years, signaling improving operational efficiency. ROE of 14.6% is modest. ROIC of 10.2% represents solid returns on invested capital versus a sector median of 5.7%.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.1% | 86.1% | 86.1% | 85.1% | 85.0% | 82.2% | 82.5% | 81.5% | 84.4% | 84.5% | 84.9% |
| Operating Margin | 64.9% | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% | 54.0% | 53.2% | 60.5% | 63.4% | 61.2% |
| Net Profit Margin | 62.0% | 62.0% | 57.5% | 57.8% | 53.6% | 56.2% | 43.1% | 43.5% | 45.5% | 111.5% | 42.7% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 14.6% | 14.6% | 13.2% | 12.0% | 9.9% | 9.8% | 8.0% | 8.1% | 8.1% | 19.0% | 7.5% |
| ROA | 2.4% | 2.4% | 2.6% | 2.1% | 1.5% | 1.6% | 2.1% | 2.8% | 2.6% | 5.6% | 2.2% |
| ROIC | 10.2% | 10.2% | 9.8% | 8.5% | 7.4% | 6.5% | 6.6% | 6.4% | 3.9% | 2.7% | 2.8% |
| ROCE | 3.6% | 3.6% | 11.0% | 9.4% | 8.3% | 7.3% | 7.2% | 7.1% | 7.9% | 7.6% | 7.2% |
CME Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
CME Group Inc. carries a Debt/EBITDA ratio of 0.8x, which is very conservative (80% below the sector average of 4.1x). The company holds a net cash position — cash of $4.4B exceeds total debt of $3.8B, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 42.0x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.14 | 0.17 | 2.07 | 1.96 |
| Debt / EBITDA | 0.83 | 0.83 | 0.80 | 0.90 | 1.02 | 1.14 | 1.11 | 0.77 | 1.01 | 12.74 | 10.78 |
| Net Debt / Equity | — | -0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.07 | 0.08 | 0.12 | 1.99 | 1.86 |
| Net Debt / EBITDA | -0.15 | -0.15 | 0.13 | 0.14 | 0.21 | 0.20 | 0.58 | 0.45 | 0.69 | 12.21 | 10.27 |
| Debt / FCF | — | -0.16 | 0.15 | 0.15 | 0.24 | 0.27 | 0.72 | 0.90 | 1.30 | 25.31 | 23.34 |
| Interest Coverage | 41.98 | 41.98 | 29.22 | 27.06 | 22.45 | 21.21 | 17.38 | 16.11 | 18.61 | 22.59 | 19.52 |
Net cash position: cash ($4.4B) exceeds total debt ($3.8B)
CME Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
CME Group Inc.'s current ratio of 92.97x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 1.02x to 92.97x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 92.97 | 92.97 | 1.01 | 1.02 | 1.01 | 1.01 | 1.01 | 1.03 | 1.01 | 1.03 | 1.03 |
| Quick Ratio | 92.97 | 92.97 | 1.01 | 1.02 | 1.01 | 1.01 | 1.01 | 1.03 | 1.01 | 1.03 | 1.03 |
| Cash Ratio | 79.27 | 79.27 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.04 | 0.05 |
| Asset Turnover | — | 0.03 | 0.04 | 0.04 | 0.03 | 0.02 | 0.04 | 0.06 | 0.06 | 0.05 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
CME Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
CME Group Inc. returns 4.1% to shareholders annually — split between a 3.8% dividend yield and 0.3% buyback yield. The payout ratio of 97.2% is elevated — while still covered by earnings, there is limited headroom for dividend increases. The earnings yield of 3.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.8% | 4.0% | 4.3% | 4.3% | 4.4% | 2.7% | 3.2% | 2.4% | 3.3% | 4.0% | 4.6% |
| Payout Ratio | 97.2% | 97.2% | 101.7% | 100.3% | 97.9% | 83.0% | 100.2% | 80.1% | 109.6% | 49.1% | 116.5% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.9% | 4.1% | 4.2% | 4.2% | 4.4% | 3.2% | 3.2% | 2.9% | 3.0% | 8.2% | 3.9% |
| FCF Yield | 4.0% | 4.3% | 4.3% | 4.5% | 4.9% | 2.8% | 3.9% | 3.4% | 3.6% | 3.5% | 4.2% |
| Buyback Yield | 0.3% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 4.1% | 4.3% | 4.3% | 4.3% | 4.4% | 2.7% | 3.3% | 2.4% | 3.3% | 4.0% | 4.6% |
| Shares Outstanding | — | $360M | $360M | $360M | $359M | $359M | $359M | $358M | $344M | $340M | $339M |
Peer Comparison
Compare CME with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CMEYou | $104B | 25.7 | 23.0 | 24.8 | 86.1% | 64.9% | 14.6% | 10.2% | 0.8 |
 ICE | $88B | 26.9 | 16.6 | 20.5 | 61.9% | 38.7% | 11.7% | 7.5% | 3.1 |
 CBOE | $36B | 33.0 | 21.7 | 31.2 | 48.9% | 32.1% | 23.4% | 17.9% | 1.0 |
 NDAQ | $51B | 28.8 | 20.1 | 25.4 | 47.9% | 28.4% | 15.3% | 8.1% | 3.3 |
 MKTX | $6B | 20.8 | 12.2 | 15.0 | 68.9% | 41.7% | 20.4% | 18.0% | 0.2 |
 MSCI | $42B | 37.3 | 24.9 | 27.3 | 82.4% | 54.7% | — | 34.9% | 3.3 |
 SPGI | $125B | 28.9 | 18.0 | 23.0 | 70.2% | 42.2% | 12.1% | 9.7% | 1.9 |
 FDS | $9B | 14.1 | 11.4 | 15.3 | 52.7% | 32.2% | 29.1% | 15.5% | 1.7 |
 TW | $23B | 29.2 | 19.8 | 20.8 | 67.3% | 41.2% | 12.0% | 9.1% | 0.3 |
 BGC | $4B | 35.8 | 10.5 | — | 100.0% | 16.8% | 13.9% | 13.0% | 3.7 |
 VIRT | $4B | 9.9 | 9.1 | 3.3 | 48.0% | 33.8% | 27.1% | 10.1% | 6.7 |
| Financial Services Median | — | 13.3 | 11.4 | 10.6 | 62.9% | 21.4% | 9.5% | 5.7% | 4.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 26 years · Updated daily
Full CME Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CME's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CME Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CME vs ICE
Side-by-side business, growth, and profitability comparison vs Intercontinental Exchange, Inc..
Start ComparisonCME — Frequently Asked Questions
Quick answers to the most common questions about buying CME stock.
What is CME Group Inc.'s P/E ratio?
CME Group Inc.'s current P/E ratio is 25.7x. The historical average is 26.5x. This places it at the 54th percentile of its historical range.
What is CME Group Inc.'s EV/EBITDA?
CME Group Inc.'s current EV/EBITDA is 23.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 18.8x.
What is CME Group Inc.'s ROE?
CME Group Inc.'s return on equity (ROE) is 14.6%. The historical average is 13.0%.
Is CME stock overvalued?
Based on historical data, CME Group Inc. is trading at a P/E of 25.7x. This is at the 54th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is CME Group Inc.'s dividend yield?
CME Group Inc.'s current dividend yield is 3.81% with a payout ratio of 97.2%.
What are CME Group Inc.'s profit margins?
CME Group Inc. has 86.1% gross margin and 64.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does CME Group Inc. have?
CME Group Inc.'s Debt/EBITDA ratio is 0.8x, indicating low leverage. A ratio below 2x is generally considered financially healthy.